Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

AM Best has assigned a Long-Term Issue Credit Rating of "bbb+" (Good) to the newly issued $1 billion, 6.35% subordinated ...

MetLife, Inc. (NYSE: MET) has been named as a 2025 CIO 100 Award Winner by Foundry CIO for My Leave Navigator. For almost 30 years, the CIO 100 Awards have recognized innovative organizations that ...

Vanguard Group Inc. increased its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 9.4% in the 4th quarter, according to the company in its most recent Form 13F filing ...

MetLife, Inc. (NYSE:MET – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen analysts that ...

MetLife, Inc. (NYSE: MET) has been named as a 2025 CIO 100 Award Winner by Foundry CIO for My Leave Navigator. For almost 30 years, the CIO 100 Awards have recognized innovative organizations that ...

Highlights,MetLife Investment Management (MIM) is the institutional asset management division of MetLife Inc., offering ...

Highlights,Horizon Investments LLC expanded its holdings in MetLife, Inc. during the fourth quarter.,Institutional investors ...

Shares of MetLife Inc. MET rose 1.69% to $83.02 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.08% to 5,675.29 and ...

We recently published a list of the 10 Most Undervalued Insurance Stocks to Buy Now. In this article, we are going to take a look at where MetLife, Inc. (NYSE:MET) stands against the other undervalued ...

AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to the newly issued $1 billion, 6.35% subordinated notes, due March 15, 2055, issued by MetLife, Inc. (MetLife ...